Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18166
Title: Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature.
Authors: Nadebaum, David P;Lee, Sze Ting;Nikfarjam, Mehrdad;Scott, Andrew M
Affiliation: Department of Molecular Imaging and Therapy, Austin Health, the University of Melbourne, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jul-2018
Citation: World journal of nuclear medicine 2018; 17(3): 195-197
Abstract: 68Ga-DOTATATE positron emission tomography (PET) is a molecular imaging technology which has shown superiority over 111In-octreotide scanning for the detection and staging of neuroendocrine tumors. We report three patients with pancreatic masses that were ultimately diagnosed as clear cell renal cell carcinoma (ccRCC) metastases on histopathology. During their initial diagnostic assessment, the three patients underwent both 18F-fluorodeoxyglucose (18F-FDG) and 68Ga-DOTATATE PET. While all three patients' lesions showed variable 18F-FDG avidity, uptake on 68Ga-DOTATATE PET was comparatively intense. The small case series illustrates the need to consider ccRCC in the differential diagnosis of 68Ga-DOTATATE avid lesions.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18166
DOI: 10.4103/wjnm.WJNM_38_17
ORCID: 0000-0001-8641-456X
0000-0003-4866-276X
0000-0002-6656-295X
PubMed URL: 30034285
ISSN: 1450-1147
Type: Journal Article
Subjects: 68Ga-DOTATATE
kidney neoplasms
positron emission tomography
renal cell carcinoma
somatostatin receptors
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.